Global Oncology, Cancer Drugs Market (Types, Treatments, Geography) - Global Industry Analysis, Growth, Trends, Opportunities, Size, Share and Forecast, 2013 - 2020 - Overview, Market Analysis, Global, Future Demand, Leaders, Company Profiles, Research Insights, Segmentation, Adoption, Sales, and Forecast
The oncology drugs are used for the treatment of cancer. The oncology drug market is a segment in the pharmaceutical drug market. The rise in new cancer cases, which is 14.1million in 2012, is the major driving factor for the drugs market. The other factors driving the market are the demand for increase in treatment by aging population, and improvements in results of treatment. As the price varies from $5,000-$92,000 per month, the rising cost is the major restraint of the oncology market There are many new brands of drug available in the market that has good success rates, but the challenge faced is the accessibility of the drugs due to high cost. The cost correction of these branded drugs can provide a good opportunity for efficient and effective treatment. The key players profiled in this report are: Bayer healthcare pharmaceuticals, Celgene, Eli Lilly & Co, ImClone Systems Inc., GlaxoSmithKline, Merck & Co, Novartis Pharmaceuticals, Pfizer Inc., Roche and Sanofi. KEY BENEFITS: • The report provides in-depth analysis about types of drugs, treatment , types of cancer and geography in the oncology drugs market • The report evaluates the key factors that prove to be drivers and restraints for the market • The report discuses the oncology drugs market based on the various segments to forecast growth till 2020. • The report discuses the market factors in various geographic regions and also explores business opportunities • The report analyzes the strategies applied by the profiled key players in the market KEY MARKET SEGMENTS GLOBAL MARKET BY, TYPE OF CANCER • Blood Cancer • Bone Cancer • Brain Cancer • Breast Cancer • Digestive/ Gastrointestinal Cancer • Endocrine Cancers • Eye Cancer • Genitourinary Cancers • Gynecologic Cancers • Head & Neck Cancers • Respiratory/Lung Cancers • Skin Cancers GLOBAL MARKET, BY TYPE OF CANCER TREATMENTS • Surgery • Chemotherapy • Radiation Therapy
• Targeted Therapy • Immunotherapy (Biologic Therapy) • Hormonal Therapy • Hyperthermia • Stem Cell Transplant • Others GLOBAL MARKET, BYTYPE OF CANCER DRUGS • Rituxan • Herceptin • Avastin • Gleevec • Velcade • Sutent • Sprycel • Nexavar • Tasigna • Afinitor / Votubia • Xgeva • Yervoy • Erbitux GLOBAL MARKET, BY GEOGRAPHY • North America • Europe • Asia pacific • RoW KEY AUDIENCE • Drug manufacturers • Hospital • Private and government research institutes • Academic institutes To Get More Information kindly Visit: http://www.alliedmarketresearch.com/oncologycancer-drugs-market
TENTATIVE TABLE OF CONTENTS: 1. INTRODUCTION 1.1. Objectives 1.2. Key Benefits 1.3. Key Deliverables
2. EXECUTIVE SUMMARY 3. MARKET OVERVIEW 3.1. Market Definition and Scope 3.2. Key Findings 3.2.1. Top Factors Impacting Long term evolution market 3.2.2. Top Investment Pockets 3.2.3. Top winning strategies 3.3. Porter’s Five force Analysis 3.4. Government Regulations 3.5. Value chain analysis 3.6. Case Studies 3.7. Market Dynamics 3.7.1. Drivers 3.7.2. Restraints 3.7.3. Opportunities 4. GLOBAL MARKET BY TYPES OF CANCER, 2012-2020 $MILLIONS 4.1. Blood Cancer 4.2. Bone Cancer 4.3. Brain Cancer 4.4. Breast Cancer 4.5. Digestive/ Gastrointestinal Cancer 4.6. Endocrine Cancers 4.7. Eye Cancer 4.8. Genitourinary Cancers 4.9. Gynecologic Cancers
4.10. Head & Neck Cancers 4.11. Respiratory/Lung Cancers 4.12. Skin Cancers 5. GLOBAL MARKET BY TYPES OF CANCER TREATMENTS , 2012-2020 $MILLIONS 5.1. Surgery 5.2. Chemotherapy 5.3. Radiation Therapy 5.4. Targeted Therapy 5.5. Immunotherapy (Biologic Therapy) 5.6. Hormonal Therapy 5.7. Hyperthermia 5.8. Stem Cell Transplant 5.9. Others 6. GLOBAL MARKET BY TYPES OF CANCER DRUGS, 2012-2020 $MILLIONS 6.1. Rituxan 6.2. Herceptin 6.3. Avastin 6.4. Gleevec 6.5. Velcade 6.6. Sutent 6.7. Sprycel 6.8. Nexavar 6.9. Tasigna 6.10. Afinitor / Votubia
6.11. Xgeva 6.12. Yervoy 6.13. Erbitux 7. GLOBAL MARKET BY GEOGRAPHY MARKET, 2012-2020 $MILLIONS 7.1. North America 7.2. Europe 7.3. Asia pacific 7.4. RoW 8. COMPANY PROFILE: 8.1. Bayer healthcare pharmaceuticals 8.2. Celgene 8.3. Eli Lilly & Co 8.4. ImClone Systems Inc. 8.5. GlaxoSmithKline 8.6. Merck & Co 8.7. Novartis Pharmaceuticals 8.8. Pfizer Inc. 8.9. Roche 8.10. Sanofi
About Us: Allied Market Research (AMR) is a Global market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact: Sona Padman 5320 SW Macadam Avenue, Suite 100, Portland, OR 97239 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 (U.S. & Canada) Fax: +1 (855) 550-5975 Email: sales@alliedmarketresearch.com Web: www.alliedmarketresearch.com